Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.7% | −4.8% | −2.0% | −3.8% | +20.3% | +21.9% | +83.3% | +61.7% | +131.8% | +777.4% |
| Peer average | −1.3% | −6.4% | −4.5% | −5.9% | +13.4% | +17.5% | +58.2% | +19.5% | +146.1% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$62 of every $1,000 in PJP is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 6.18% | $617.82 | 218K | $36.3M |
| 2 | LLYEli Lilly | Healthcare | 6.04% | $604.26 | 26K | $35.5M |
| 3 | ABBVAbbVie | Healthcare | 5.89% | $588.82 | 122K | $34.6M |
| 4 | AMGNAmgen | Healthcare | 5.46% | $546.45 | 73K | $32.1M |
| 5 | JNJJohnson & Johnson | Healthcare | 5.40% | $539.84 | 119K | $31.7M |
| 6 | PFEPfizer | Healthcare | 5.32% | $532.07 | 1.1M | $31.2M |
| 7 | ABTAbbott Laboratories | Healthcare | 4.93% | $492.97 | 279K | $28.9M |
| 8 | MRKMerck | Healthcare | 4.69% | $468.60 | 207K | $27.5M |
| 9 | AMRXAmneal Pharmaceuticals | Healthcare | 3.76% | $375.55 | 1.0M | $22.0M |
| 10 | VTRSViatris | Healthcare | 3.74% | $374.10 | 1.1M | $22.0M |
| 11 | BIIBBiogen | Healthcare | 3.52% | $352.18 | 84K | $20.7M |
| 12 | PRGOPerrigo | Healthcare | 3.49% | $348.53 | 1.3M | $20.5M |
| 13 | REGNRegeneron Pharmaceuticals | Healthcare | 3.48% | $348.31 | 22K | $20.5M |
| 14 | TARSTarsus Pharmaceuticals | Healthcare | 3.42% | $342.04 | 259K | $20.1M |
| 15 | UTHRUnited Therapeutics | Healthcare | 3.39% | $339.17 | 36K | $19.9M |
of the $108B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 6.18% |
| 2 | LLY | Eli Lilly & | 6.04% |
| 3 | ABBV | AbbVie | 5.89% |
| 4 | AMGN | Amgen | 5.46% |
| 5 | JNJ | Johnson & Johnson | 5.40% |
| 6 | PFE | Pfizer | 5.32% |
| 7 | ABT | Abbott Laboratories | 4.93% |
| 8 | MRK | Merck & | 4.69% |
| 9 | AMRX | Amneal Pharmaceuticals | 3.76% |
| 10 | VTRS | Viatris | 3.74% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.30 |
| Jun 22, 2026 | Jun 26, 2026 | $0.27 |
| Mar 23, 2026 | Mar 27, 2026 | $0.31 |
| Dec 22, 2025 | Dec 26, 2025 | $0.25 |
| Sep 22, 2025 | Sep 26, 2025 | $0.24 |
| Jun 23, 2025 | Jun 27, 2025 | $0.27 |
| Mar 24, 2025 | Mar 28, 2025 | $0.27 |
| Dec 23, 2024 | Dec 27, 2024 | $0.22 |
| Sep 23, 2024 | Sep 27, 2024 | $0.20 |
| Jun 24, 2024 | Jun 28, 2024 | $0.21 |
| Mar 18, 2024 | Mar 22, 2024 | $0.17 |
| Dec 18, 2023 | Dec 22, 2023 | $0.19 |